Articles by My Road to Half a Million SA

  • Posted on 10/12/17

    Johnson & Johnson: The Need To Increase Margins, Growth

    Johnson & Johnson's (JNJ) pharmaceutical segment is currently firing on all cylinders, but the same cannot be said about its consumer segment. In 2015, the segment . . .

  • Posted on 10/3/17

    Pfizer: A Good Buy

    I find Pfizer (PFE) a truly wonderful business. The reason for this is because the company is able to present its investors year after year with . . .

  • Posted on 9/26/17

    Johnson & Johnson Is Not A Good Buy

    By applying different what-if scenarios to Johnson & Johnson (JNJ), I arrived at a conclusion that a fair value would be more likely in the 70$ . . .

  • Posted on 9/12/17

    Johnson & Johnson: How To Decrease Your Investment Returns

    Writing options for great companies such as Johnson & Johnson (JNJ) is a sure way to decrease your returns. Option writing seems to be a fashionable . . .

  • Posted on 9/4/17

    Johnson & Johnson: How Does An $11 Special Dividend Sound To You?

    The price Johnson & Johnson (JNJ) paid for acquiring Actelion has most likely been a bit too high and destroyed shareholder wealth.Even through the acquisition of . . .

  • Posted on 8/8/17

    Waters Is Minting Money

    I find Waters (WAT) a truly wonderful business. The reason for this is because the company is able to present its investors year after year with . . .